Contact Us

Get 30% Free Customization on This Report

Published Date: October, 2019

Respiratory Tract Infection Market (Drugs - Antibiotics, Non-steroidal Anti-inflammatory Drugs, Nasal Decongestants, Cough Suppressants, and Other Drugs; Disease Indication - Upper Respiratory Tract Infection, and Lower Respiratory Tract Infection; Distribution Channels - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on the respiratory tract infection market provides an in-depth analysis of segments and sub-segments in the global as well as regional respiratory tract infection market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional respiratory tract infection market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global respiratory tract infection market. According to the report, the global respiratory tract infection market is projected to grow at a CAGR of 6.4% over the forecast period of 2019-2025.

 

Market Insight

Respiratory tract infection is defined as any infectious disease of the upper or lower respiratory tract. Upper respiratory tract infections (URTIs) include laryngitis, common cold, pharyngitis/tonsillitis, acute rhinosinusitis acute rhinitis, and acute otitis media. Lower respiratory tract infections (LRTIs) include acute bronchitis, bronchiolitis, pneumonia, and tracheitis. The respiratory tract infection market is expected to grow during the forecast period.

 

Increasing occurrences of respiratory illness is the major factor driving the growth of the respiratory tract infection market across the globe. According to the World Health Organization, nearly 334 million people suffer from asthma, the most common chronic disease of childhood affecting 14% of all children globally. Furthermore, lung cancer kills 1.6 million people each year and is the most deadly cancer. Moreover, the increase in the elderly population also boosts the growth of the market over the forecast period. However, the growing frequency of antibiotic resistance and adverse events relating to the consumption of NSAIDs will hamper the growth of the respiratory infection market. On the other hand, rapid industrialization in the developing countries leading to increased air and water pollution creates an opportunity for the growth of the market in the upcoming years.

 

North America is leading the respiratory tract infection market due to an increase in the prevalence of upper respiratory tract infections. Furthermore, the rise in the elderly population also boosts the growth of the market in the region. Moreover, the rise in multi-drug resistance bacterial infection among children and immune-compromised adults also helps in the growth of the market in the North American region. The Asia Pacific is expected to grow at a faster rate during the forecast period owing to the rise in patient awareness, better health care infrastructure, and facilities, high disposable income, occurrence of an unhealthy lifestyle, etc.

 

Segment Covered

The report on the global respiratory tract infection market covers segments such as drugs, disease indication, and distribution channels. On the basis of drugs, the sub-markets include antibiotics, non-steroidal anti-inflammatory drugs, nasal decongestants, cough suppressants, and other drugs. On the basis of disease indication, the sub-markets include upper respiratory tract infection, and lower respiratory tract infection. On the basis of distribution channels, the sub-markets include hospital pharmacies, retail pharmacies, and online pharmacies.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Abbott, AstraZeneca, Teva Pharmaceutical Industries Ltd., AbbVie Inc., GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, and Sanofi S.A.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of respiratory tract infection market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter